Morbilliform drug eruption is a form of allergic reaction. It is mediated by cytotoxic T-cells and classified as a Type IV immune reaction. The target of attack may be drug, a metabolite of the drug, or a protein bonded to the drug. Inflammation follows the release of cytokines and other effector immune cells. What are the clinical features of ...

Exanthematous (maculopapular) drug eruption, also called morbilliform (measles-like) drug-induced exanthem, is the most common drug hypersensitivity reaction .

2021年3月8日 · Exanthematous drug eruption, also known as a morbilliform or maculopapular drug eruption, is the most common type of drug hypersensitivity reaction [1]. Diagnosis of exanthematous drug eruption should be suspected in a patient receiving drug treatment who presents with a new onset rash.

Morbilliform drug eruptions, also called exanthematous drug eruptions, are a form of delayed cutaneous hypersensitivity characterized by erythematous macules or papules that coalesce to form large plaques. The eruption usually occurs 5 days to 2 weeks after...

2019年3月13日 · The onset of a morbilliform eruption (MDE; also known as exanthematous or maculopapular drug eruption) typically occurs within 7 to 10 days after the initiation of the culprit drug. Occasionally a 14-day window has been noted.

2025年1月31日 · In this review, we aim to risk stratify early morbilliform eruptions into “high-risk” morbilliform eruptions (including SCARs and GVHD) and “low-risk” eruptions (most often drug exanthems). In doing so, we offer a framework for early differentiation of etiologies of the morbilliform rash.

2025年1月31日 · Morbilliform eruptions, which are a clinical reaction pattern characterized by erythematous macules and papules coalescing into patches that cover most of the skin surface, are one of the most common cutaneous findings in the inpatient setting. In the hospital setting, most causes are benign and due …

2018年11月3日 · Morbilliform drug eruptions are the most common type of cutaneous adverse drug eruption comprising 75–90% of all drug reactions. Frequently implicated medications include: antibiotics (penicillins, sulfonamides, cephalosporins), anticonvulsants, NSAIDs, and calcium channel blockers, although eruptions can occur with any medication

Exanthematous drug eruption, also called morbilliform or maculopapular drug eruption, is the most common type of drug hypersensitivity reaction . They are characterized by a diffuse and symmetric eruption of erythematous macules or small papules occurring approximately one week or, in previously sensitized individuals, as early as one or two ...

rtriginous and flexural exanthema (SDRIFE), whose severity is uncertain. Morbilliform rash, also known as "maculopapular" drug eruption (MPE), morbilliform drug eruption (MDE) and "exanthematous" drug eruption, represents 50-90% of all CADRs.1 Morbilliform rash resem.